1 |
NCT03030209 |
Recruiting |
Risk Factors for the Development of Diabetes Mellitus After Distal Pancreatectomy |
|
- Procedure: Distal pancreatectomy
|
Observational |
|
- Peking Union Medical College Hospital
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Number of participants with new-onset diabetes mellitus as defined by American Diabetes Association
- Number of participants with new-onset prediabetes as defined by American Diabetes Association
- Number of participants with new-onset exocrine insufficiency
|
800 |
All |
Child, Adult, Senior |
NCT03030209 |
PUMCH-GS03 |
|
January 2000 |
June 2017 |
December 2017 |
January 24, 2017 |
January 24, 2017 |
|
- Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Beijing, China
|
2 |
NCT02689362 |
Recruiting |
Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2) |
- Diabetes Mellitus, Type 2
|
- Drug: Evogliptin
- Drug: Sitagliptin
- Drug: Placebo Evogliptin
- Drug: Placebo Sitagliptin
|
Interventional |
Phase 2 |
- Eurofarma Laboratorios S.A.
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Absolute variation of the values obtained in the baseline for the HbA1c
- Absolute variation of the values obtained in the baseline for the parameter, fasting blood glucose.
- Absolute variation of the values obtained in the baseline for the parameter, body weight.
|
144 |
All |
20 Years to 75 Years (Adult, Senior) |
NCT02689362 |
EF144 |
EVOLUTION |
August 8, 2017 |
December 2018 |
December 2018 |
February 23, 2016 |
March 26, 2018 |
|
- Centro de Estudos em Diabetes e Hipertensão
Fortaleza, Ceará, Brazil - Hospital Universitário João de Barros Barreto - HUJBB
Belém, Pará, Brazil - CCBR Brasil Centro de Pesquisas e Analises Clinicas Ltda
Rio de Janeiro, Brazil - (and 7 more...)
|
3 |
NCT03352674 |
Recruiting |
Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus Patients |
|
- Drug: Insulin Glargine Ezelin
- Drug: Insulin Glargine Pen Injector [Lantus]
|
Interventional |
Phase 2 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Incidence of immune response
- HbA1c
- Fasting blood glucose
- (and 2 more...)
|
120 |
All |
18 Years and older (Adult, Senior) |
NCT03352674 |
IndonesiaU-01 |
|
September 2016 |
June 1, 2018 |
June 1, 2018 |
November 24, 2017 |
November 27, 2017 |
|
- Department of Internal Medicine Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia
Jakarta Pusat, Jakarta, Indonesia
|
4 |
NCT03199053 |
Recruiting |
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old |
- Diabetes Mellitus, Type 2
|
- Drug: Dapagliflozin
- Drug: Saxagliptin
- Drug: Placebo
|
Interventional |
Phase 3 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Change from baseline in HbA1c at Week 26
- Change from baseline in Fasting Plasma Glucose at Week 26
- Percentage of subjects with baseline HbA1c ≥ 7%, who achieve an HbA1c level < 7.0% at Week 26
|
243 |
All |
10 Years to 18 Years (Child, Adult) |
NCT03199053 |
D1680C00019 2015-005042-66 |
|
October 11, 2017 |
October 21, 2020 |
September 22, 2021 |
June 26, 2017 |
March 30, 2018 |
|
- Research Site
Saraland, Alabama, United States - Research Site
Sacramento, California, United States - Research Site
Washington, District of Columbia, United States - (and 152 more...)
|
5 |
NCT03291834 |
Recruiting |
Sports Participation in Children and Adolescents With Type 1 Diabetes Mellitus |
|
|
Observational |
|
|
Other |
- Observational Model: Cohort
- Time Perspective: Retrospective
|
- Participation at sports
- Occurence of hypoglycemia or hyperglycemia
- Measures taken to prevent hypoglycemia or hyperglycemia
|
100 |
All |
8 Years to 18 Years (Child, Adult) |
NCT03291834 |
JessaH_PedEndo002 |
|
August 15, 2017 |
April 2018 |
April 2018 |
September 25, 2017 |
March 1, 2018 |
|
- Jessa Hospital
Hasselt, Limburg, Belgium
|
6 |
NCT03160196 |
Not yet recruiting |
Efficacy of an Electronic System to Support Clinical Decisions in Adults With Type 2 Diabetes Mellitus. |
- Diabetes Mellitus, Type 2
|
- Other: Clinical Decision Support System
- Other: Usual care based on clinical practice guideline
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Proportions of participants with normal Hb1Ac
|
1768 |
All |
18 Years to 100 Years (Adult, Senior) |
NCT03160196 |
|
OSI-DM |
January 2018 |
September 2019 |
September 2019 |
May 19, 2017 |
May 19, 2017 |
|
|
7 |
NCT02940418 |
Recruiting |
Use of Stem Cells in Diabetes Mellitus Type 1 |
|
- Biological: Adipose mesenchymal cells with bone marrow mononuclear cells
|
Interventional |
Phase 1 |
- Sophia Al-Adwan
- University of Jordan
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Safety of using allogenic ASC assessed by any adverse events
|
20 |
All |
18 Years to 35 Years (Adult) |
NCT02940418 |
T1DM.UJCTC |
|
February 19, 2017 |
January 2018 |
July 2018 |
October 20, 2016 |
May 8, 2017 |
|
- Cell Therapy Center
Amman, Jordan
|
8 |
NCT03387787 |
Not yet recruiting |
Evaluation of Glycaemic Control Using GlucoTab® With Insulin Degludec in Hospitalized Patients With Diabetes Mellitus Type 2 |
|
- Device: GlucoTab
- Drug: Insulin Degludec
|
Interventional |
Phase 2 Phase 3 |
- University Hospital Inselspital, Berne
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Blood Glucose in target range in percent
- Random blood glucose <9.9 mmol/l in percent
- Number of severe hypoglycaemic episodes (defined as symptomatic or asymptomatic hypoglycaemia requiring third party help)
- (and 23 more...)
|
15 |
All |
18 Years and older (Adult, Senior) |
NCT03387787 |
UDEM_GlucoTab |
|
March 1, 2018 |
January 1, 2019 |
January 1, 2019 |
January 2, 2018 |
January 2, 2018 |
|
- Division of Endocrinology, Diabetes, Clinical Nutrition & Metabolism, University Hospital Berne, Switzerland
Berne, Switzerland
|
9 |
NCT02954601 |
Recruiting |
A Study of Single and Multiple Doses of ORMD-0801 (Study Drug) or Placebo in Subjects With T2 (Type 2) DM (Diabetes Mellitus) |
|
- Drug: ORMD-0801 (qd)
- Drug: ORMD-0801 (bid)
- Drug: ORMD-0801 (tid)
- Other: Placebo
|
Interventional |
Phase 2 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Compare pre-treatment (Day 3) to end of treatment (Day 8) 24-hour Continuous Glucose Monitoring (CGM) glucose for single and multiple doses of ORMD-0801 vs placebo.
- To evaluate safety parameter ECG for single and multiple doses of ORMD-0801 vs placebo.
- To evaluate safety parameter hyperglycemia ( for single and multiple doses of ORMD-0801 vs placebo.hyperglycemia,
- To evaluate safety parameter C-peptide for single and multiple doses of ORMD-0801 vs placebo.
|
30 |
All |
20 Years to 75 Years (Adult, Senior) |
NCT02954601 |
ORA-D-012 |
|
October 2016 |
November 2017 |
December 2017 |
November 3, 2016 |
November 8, 2016 |
|
- Orange County Research Center
Tustin, California, United States
|
10 |
NCT02924207 |
Recruiting |
Electronic Decision Support for Intervention in Poorly Controlled Type 2 Diabetes |
|
- Other: PATH electronic decision support tool
|
Interventional |
Not Applicable |
- St Elizabeth Healthcare
- Eilerman Endocrinology & Magnolia Associates
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- change in hemoglobin A1c from baseline
- change in patient's perception of cost of diabetes medicine and side effects
- actual cost and change in frequency of drug side effects
|
200 |
All |
18 Years and older (Adult, Senior) |
NCT02924207 |
6/2016-018 |
PATH |
September 2016 |
October 2018 |
October 2018 |
October 5, 2016 |
January 13, 2017 |
|
- St. Elizabeth Healthcare
Covington, Kentucky, United States
|
11 |
NCT02744300 |
Recruiting |
Balance After Baby Intervention for Women With Recent Gestational Diabetes |
- Gestational Diabetes Mellitus
|
- Behavioral: BABI-2 Lifestyle Intervention
|
Interventional |
Not Applicable |
- Brigham and Women's Hospital
- University of Colorado, Denver
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Investigator)
- Primary Purpose: Prevention
|
- Weight loss
- Diabetes
- Number of participants with a fasting glucose level greater than 100 mg/dL
- Number of participants with either: a HbA1c value greater than or equal to 5.7; or a 2 hour value on a 75 g oral glucose tolerance test of greater than or equal to 140
|
180 |
Female |
18 Years and older (Adult, Senior) |
NCT02744300 |
6201.25-S01 |
BABI2 |
June 2016 |
October 2018 |
October 2018 |
April 20, 2016 |
July 13, 2017 |
|
- University of Colorado Denver
Denver, Colorado, United States
|
12 |
NCT03416127 |
Not yet recruiting |
Effect of Propolis or Metformin Administration on Glycemic Control in Patients With Diabetes Mellitus Type 2 |
- Diabetes Mellitus, Type 2
|
- Drug: Propolis
- Drug: Metformin
- Drug: Placebo
|
Interventional |
Phase 2 |
- University of Guadalajara
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Changes in fasting glucose levels after 12 weeks of intervention with propolis, metformin and placebo
- Changes in postprandial glucose levels after 12 weeks of intervention with propolis, metformin and placebo
- Changes in glycosylated hemoglobin (A1C) after 12 weeks of intervention with propolis, metformin and placebo
- (and 15 more...)
|
36 |
All |
30 Years to 60 Years (Adult) |
NCT03416127 |
PROPOLIS-METFORMIN-DM2 |
|
March 1, 2018 |
March 1, 2019 |
May 1, 2019 |
January 30, 2018 |
February 2, 2018 |
|
- Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara
Guadalajara, Jalisco, Mexico
|
13 |
NCT02722655 |
Recruiting |
Cohort of Mexican Children With Diabetes Mellitus (CMC-DM) |
|
|
Observational |
|
- Hospital Regional de Alta Especialidad del Bajio
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Diabetic retinopathy
- Peripheral diabetic neuropathy
- Nerve damage
- (and 13 more...)
|
500 |
All |
1 Month to 17 Years (Child) |
NCT02722655 |
2015-018 |
CMC-DM |
March 2008 |
December 2020 |
December 2030 |
March 30, 2016 |
August 22, 2017 |
|
- Hospital Regional de Alta Especialidad del Bajío
Leon, Guanajuato, Mexico
|
14 |
NCT03390959 |
Recruiting |
Effectiveness of Proprioceptive Training on Plantar Pressure, Balance, Posture and Gait in Individuals With Diabetes Mellitus Type 2 |
- Diabetes Mellitus, Type 2
|
- Other: Proprioceptive Training
- Other: Control Group
|
Interventional |
Not Applicable |
- Kelly Antunes e Silva Oliveira
- Universidade Federal de Pernambuco
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Plantar Pressure
- Balance
- Posture
- (and 2 more...)
|
14 |
All |
45 Years to 80 Years (Adult, Senior) |
NCT03390959 |
Proprioceptive DM2 Feedback N.2.052.913 |
|
May 10, 2017 |
March 30, 2018 |
March 30, 2018 |
January 5, 2018 |
January 5, 2018 |
|
- Maria das Graças Araujo
Recife, Pernambuco, Brazil
|
15 |
NCT03421379 |
Recruiting |
A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus |
|
- Drug: Glucagon Nasal Powder
- Drug: Glucagon Hydrochloride Solution
|
Interventional |
Phase 3 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Percentage of Participants Achieving Treatment Success During Controlled Insulin-Induced Hypoglycemia
- Pharmacodynamics (PD): Change from Baseline in Maximal Blood Glucose (BGmax) of Glucagon Nasal Powder and Glucagon Hydrochloride IM
- PD: Time to Maximal Concentration (Tmax) of Glucagon Nasal Powder and Glucagon Hydrochloride IM
- (and 3 more...)
|
75 |
All |
18 Years to 70 Years (Adult, Senior) |
NCT03421379 |
16962 I8R-JE-IGBJ |
|
February 21, 2018 |
July 31, 2018 |
August 31, 2018 |
February 5, 2018 |
March 27, 2018 |
|
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Fukuoka, Japan - For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Shinjuku-Ku, Japan - For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Sumida, Japan - For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Tokyo, Japan
|
16 |
NCT02681185 |
Not yet recruiting |
Efficacy of a Virtual Care Clinic in the Management of Diabetes Mellitus |
|
- Other: Virtual Care
- Other: Standard of Care
|
Interventional |
Not Applicable |
- Endocrine Research Society
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- HbA1c
- Survey of Healthcare Utilization
- Survey of Quality of Life
|
100 |
All |
19 Years to 75 Years (Adult, Senior) |
NCT02681185 |
Virtual Care |
|
December 2017 |
June 2020 |
June 2020 |
February 12, 2016 |
August 15, 2017 |
|
- Endocrine Research Society
Vancouver, British Columbia, Canada
|
17 |
NCT02663245 |
Recruiting |
INTEGRA Study: Primary Care Intervention in Type 2 Diabetes Patients With Poor Glycaemic Control |
|
- Other: Intervention 1
- Other: Intervention 2
|
Interventional |
Not Applicable |
- Jordi Gol i Gurina Foundation
- Sanofi
|
Other / Industry |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Health Services Research
|
- Glycaemic control measured by HbA1c
- lipid profile control as measured by the mean concentration of LDL-cholesterol, non-HDL cholesterol and triglycerides
- measurement of systolic blood pressure and of diastolic blood pressure
- (and 7 more...)
|
648 |
All |
30 Years to 80 Years (Adult, Senior) |
NCT02663245 |
P14/129 |
|
December 2015 |
December 2018 |
December 2018 |
January 26, 2016 |
September 1, 2017 |
|
- Laura Montero
Tàrrega, LLeida, Spain
|
18 |
NCT02844803 |
Recruiting |
Study of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients |
|
- Drug: Combination of Metformin + S. Baicalensis
- Drug: Combination of Metformin + Placebo
|
Interventional |
Early Phase 1 |
- Namyi Gu
- DongGuk University
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
|
- Change of serum glucose level after 8 weeks from baseline
|
20 |
All |
20 Years to 75 Years (Adult, Senior) |
NCT02844803 |
S.baicalensis-Metformin |
|
July 2016 |
June 2017 |
|
July 26, 2016 |
August 3, 2016 |
|
- Dongguk University Ilsan Hospital
Goyang, Gyeonggi, Korea, Republic of
|
19 |
NCT02942056 |
Not yet recruiting |
The Effect of Cinnamon Cassia on Diabetes Control and Cardiometabolic Risk Factors in Adults With Type 2 Diabetes Mellitus |
|
- Drug: Cinnamon
- Drug: placebo
|
Interventional |
Phase 2 |
- Oregon Health and Science University
|
Other |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Type 2 DM control
- lipid control
- obesity
|
250 |
All |
30 Years to 65 Years (Adult) |
NCT02942056 |
OHSU IRB # 11386 |
|
January 2017 |
January 2020 |
January 2020 |
October 21, 2016 |
October 21, 2016 |
|
|
20 |
NCT02974413 |
Recruiting |
Effectiveness of Self-care Rests on Knowledge, Self-care and Cardiometabolic Control of Adult Men With Diabetes Mellitus |
|
- Behavioral: self-care supported
|
Interventional |
Not Applicable |
- Universidade Estadual de Maringá
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Glycemic control
- Self-care attitudes
- Self-efficacy (or Empowerment)
- (and 5 more...)
|
140 |
Male |
40 Years to 70 Years (Adult, Senior) |
NCT02974413 |
State University of Maringá |
|
March 2016 |
November 2016 |
|
November 28, 2016 |
November 28, 2016 |
|
- Universidade Estadual de Maringá
Maringá, Paraná, Brazil
|
21 |
NCT03113110 |
Recruiting |
Empagliflozin in Post-Transplantation Diabetes Mellitus |
- Posttransplant Diabetes Mellitus
|
- Drug: Empagliflozin 10 mg
|
Interventional |
Phase 2 |
- Medical University of Vienna
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- OGTT-derived 2-hour blood glucose level
|
16 |
All |
18 Years and older (Adult, Senior) |
NCT03113110 |
EUDRACT-Nr: 2016-001580-37 EK-No. 1366/2016 |
EMPTRA-DM |
January 15, 2017 |
December 31, 2019 |
December 31, 2019 |
April 13, 2017 |
April 13, 2017 |
|
- Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria
Vienna, Austria
|
22 |
NCT02569151 |
Not yet recruiting |
20 Years Results by HBP and DBP in Patients With Type 2 Diabetes Mellitus After Following-up |
|
- Device: HBP & CBP measurement using systo 130 mmHg
|
Observational |
|
- Kyuzi Kamoi
- Nagaoka Red Cross Hospital
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Death
- new, worsened, or improved microvascular and macrovascular events
|
600 |
All |
20 Years to 100 Years (Adult, Senior) |
NCT02569151 |
9-Kamoi |
|
April 2016 |
March 2027 |
April 2027 |
October 6, 2015 |
October 6, 2015 |
|
|
23 |
NCT03010956 |
Recruiting |
Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication. |
|
|
Observational |
|
|
Other |
- Observational Model: Case-Crossover
- Time Perspective: Prospective
|
- Differences in pulse wave velocity at baseline and 3, 6 and 12 months after the modification of the antidiabetic medication.
- Differences in augmentation index at baseline and 3, 6 and 12 months after the modification of the antidiabetic medication.
- Differences in endothelial glycocalyx at baseline and 3, 6 and 12 months after the modification of the antidiabetic medication.
- (and 3 more...)
|
60 |
All |
18 Years to 70 Years (Adult, Senior) |
NCT03010956 |
S-DM-ATTIKON |
|
November 2014 |
June 2017 |
November 2017 |
January 5, 2017 |
January 5, 2017 |
|
- ''Attikon'' University General Hospital
Haidari, Athens, Attiki, Greece
|
24 |
NCT02776397 |
Recruiting |
Relationship of Haptoglobin Phenotype to Vascular Function and Response to Vitamin E Supplementation in Patients With Diabetes Mellitus Type 2: The EVAS Trial |
|
- Dietary Supplement: Vitamin E
- Other: Placebo
|
Interventional |
Not Applicable |
- Tan Tock Seng Hospital
- Lee Kong Chian School of Medicine, Nanyang Technological University
- National Medical Research Council (NMRC), Singapore
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Prevention
|
- Endothelial function
- Aortic artery stiffness
- Carotid Artery Intima Media Thickness
- (and 5 more...)
|
300 |
All |
21 Years to 80 Years (Adult, Senior) |
NCT02776397 |
EVAS001 Version 4 |
EVAS |
June 2015 |
June 2018 |
July 2018 |
May 18, 2016 |
May 19, 2016 |
|
- Tan Tock Seng Hospital
Singapore, Singapore
|
25 |
NCT01055093 |
Recruiting |
Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients |
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
|
|
Observational |
|
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Change of insulin sensitivity (M-Value)
- Change of insulin secretion
- Incidence of any diabetic complication
|
2000 |
All |
18 Years to 69 Years (Adult, Senior) |
NCT01055093 |
GDC-Study-01 |
GDC |
September 2005 |
September 2025 |
September 2035 |
January 25, 2010 |
September 12, 2017 |
|
- German Diabetes Center
Düsseldorf, North-Rhine Westphalia, Germany
|
26 |
NCT03362151 |
Recruiting |
A Clinical Study to Investigate and Compare the Impact of High Protein Pasta, Lower Protein Pasta and White Rice on Blood Sugar Control in People With Type 1 Diabetes Mellitus (T1DM) |
- Diabetes Mellitus, Type 1
|
- Other: Regular pasta
- Other: High protein pasta
- Other: White rice
|
Interventional |
Not Applicable |
- Sansum Diabetes Research Institute
- Harvard University
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Delta glucose (maximum rise from baseline glucose) mg/dL
- Incremental area under the curve (area)
- Time to peak glucose level (minutes)
- percent time glucose <70 mg/dL
|
30 |
All |
18 Years to 75 Years (Adult, Senior) |
NCT03362151 |
IRB17-1316 |
|
January 1, 2018 |
August 1, 2018 |
December 1, 2018 |
December 5, 2017 |
January 29, 2018 |
|
- Sansum Diabetes Research Institute
Santa Barbara, California, United States
|
27 |
NCT00339885 |
Recruiting |
Mapping Genes for Type 2 (Non-Insulin Dependent) Diabetes Mellitus |
- Non-Insulin Dependent Diabetes Mellitus
|
|
Observational |
|
- National Human Genome Research Institute (NHGRI)
- National Institutes of Health Clinical Center (CC)
|
NIH |
|
|
60000 |
All |
12 Months and older (Child, Adult, Senior) |
NCT00339885 |
999995030 OH95-HG-N030 |
|
March 24, 1995 |
|
|
June 21, 2006 |
April 17, 2018 |
|
- Helsinki University Hospital District
Helsinki, Finland - National Public Health Institute
Helsinki, Finland - University of Kuopio
Kuopio, Finland - (and 4 more...)
|
28 |
NCT02890693 |
Recruiting |
Improving Cardio-metabolic and Mental Health in Women With Gestational Diabetes Mellitus and Their Offspring |
- Gestational Diabetes Mellitus
|
- Behavioral: interdisciplinary lifestyle and psychosocial intervention
|
Interventional |
Not Applicable |
- University of Lausanne Hospitals
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- maternal weight measured on calibrated scale
- Self-reported symptoms of depression (mother) measured by Edinburgh Postnatal Depression Scale
- Body composition (mother and infant) measured by bioelectrical impedance analysis
- (and 24 more...)
|
200 |
All |
18 Years and older (Adult, Senior) |
NCT02890693 |
2016-00745 |
MySweetHeart |
September 2016 |
September 2020 |
September 2020 |
September 7, 2016 |
October 11, 2016 |
|
- University Hospital Lausanne
Lausanne, Vaud, Switzerland
|
29 |
NCT02812498 |
Recruiting |
Teleconsultation in Type 1 Diabetes Mellitus |
|
- Other: Teleconsultation
- Other: Standard
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Health Services Research
|
- glycosylated hemoglobin HbA1c
- HbA1c glycosylated hemoglobin
- Patient satisfactory assessment by a questionnaire on their perception of advantages (diabetes management, comfort and convenience) and limits (technical problems, poor interaction with physicians) of the service
- Cost analysis by patient estimation through a questionnaire of the overall cost and time saved thanks to the service
|
150 |
All |
5 Years to 50 Years (Child, Adult) |
NCT02812498 |
535-B-102014 |
TELEDIAB |
January 2015 |
June 2017 |
July 2017 |
June 24, 2016 |
June 24, 2016 |
|
- AO Ospedale Civile Legnano Legnano
Legnano, Italy - ASST Grande Ospedale Metropolitano Niguarda
Milano, Italy
|
30 |
NCT03181737 |
Recruiting |
Psychological Online-training to Optimize Adherence in Patients With Type-II Diabetes |
|
- Behavioral: Covivio/Relaxio
|
Interventional |
Not Applicable |
- Philipps University Marburg Medical Center
- Prof. Dr. Yvonne Nestoriuc
- Gaia AG
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Diabetes Self-Management Questionnaire (DSMQ-R)
- Glycemic control
- GLTEQ (Godin- Leisure- Time Exercise Questionnaire)
- (and 5 more...)
|
300 |
All |
18 Years and older (Adult, Senior) |
NCT03181737 |
2016-42k-r |
ONSIDE |
August 3, 2017 |
October 1, 2018 |
April 1, 2019 |
June 9, 2017 |
August 4, 2017 |
|
- Department of Psychology, Philipps University Marburg
Marburg, Hessen, Germany
|
31 |
NCT02649374 |
Recruiting |
Gut Microbiome and Gestational Diabetes Mellitus |
- Gestational Diabetes Mellitus
|
- Behavioral: Dietary, Exercise and lifestyle modifications
|
Interventional |
Not Applicable |
- Rabin Medical Center
- Clalit Health Services
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Bacterial population diversity
|
400 |
Female |
18 Years to 45 Years (Adult) |
NCT02649374 |
0263-15-RMC |
|
February 2016 |
December 2018 |
December 2019 |
January 7, 2016 |
April 11, 2018 |
|
- Rabin Medical Center
Petach-Tikva, Israel
|
32 |
NCT02394158 |
Recruiting |
Preventing Recurrent Gestational Diabetes With Metformin |
- Gestational Diabetes Mellitus
|
- Drug: Metformin
- Drug: placebo
|
Interventional |
Phase 4 |
- Imperial College London
- Imperial College Healthcare NHS Trust
- London North West Healthcare NHS Trust
- The Novo Nordisk UK Research Foundation
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Prevention
|
- Development of Gestational Diabetes at any point during the course of pregnancy
- Maternal gestational weight gain
- Requirement for insulin therapy
- (and 5 more...)
|
112 |
Female |
18 Years to 45 Years (Adult) |
NCT02394158 |
14SM1971 2014-001244-38 |
PRoDroME |
December 2014 |
July 2017 |
July 2017 |
March 20, 2015 |
November 10, 2016 |
|
- Imperial College NHS Trust
London, United Kingdom - London North West Healthcare Trust
London, United Kingdom
|
33 |
NCT03436992 |
Recruiting |
Estrogen and Diabetes |
- Diabetes Mellitus, Type 1
|
- Dietary Supplement: Antioxidant Cocktail
- Dietary Supplement: Resveratrol
- Other: Placebo
|
Interventional |
Not Applicable |
- Augusta University
- National Heart, Lung, and Blood Institute (NHLBI)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Change in Flow-Mediated Dilation (FMD)
|
198 |
All |
18 Years to 40 Years (Adult) |
NCT03436992 |
E2 and D 1R01HL137087-01A1 |
|
April 17, 2018 |
May 1, 2024 |
May 1, 2024 |
February 19, 2018 |
April 19, 2018 |
|
- Augusta University
Augusta, Georgia, United States - Georgia Prevention Institute
Augusta, Georgia, United States
|
34 |
NCT03240432 |
Recruiting |
Wireless Innovation for Seniors With Diabetes Mellitus |
|
|
Interventional |
Not Applicable |
- Jaeb Center for Health Research
- The Leona M. and Harry B. Helmsley Charitable Trust
- Juvenile Diabetes Research Foundation
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Time spent with glucose level <70 mg/dL
- Change in HbA1c
- Change in QOL: Preferring Hypoglycemia Scale
- (and 8 more...)
|
200 |
All |
60 Years and older (Adult, Senior) |
NCT03240432 |
WISDM |
WISDM |
September 26, 2017 |
October 2019 |
October 2019 |
August 7, 2017 |
March 5, 2018 |
|
- University of Southern California
Beverly Hills, California, United States - Scripps Whittier Diabetes Institute
La Jolla, California, United States - University of Colorado - Barbara Davis Center
Aurora, Colorado, United States - (and 19 more...)
|
35 |
NCT02327286 |
Recruiting |
Randomized Clinical Trial of Lifestyle Interventions to Prevent Diabetes in Women With Previous Gestational Diabetes |
- Diabetes Mellitus
- Diabetes, Gestational
|
- Behavioral: Promote and support healthy behaviors
|
Interventional |
Phase 3 |
- Federal University of Rio Grande do Sul
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Eli Lilly and Company
- (and 4 more...)
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Prevention
|
- Incident diabetes mellitus
- Weight at one year post randomization
|
740 |
Female |
18 Years and older (Adult, Senior) |
NCT02327286 |
563942/2010-0 U1111-1165-0608 00914312.0.1001.5327 |
LINDA-Brasil |
January 2015 |
December 2019 |
December 2019 |
December 30, 2014 |
September 2, 2016 |
|
- Centro de Estudos em Diabetes e Hipertensão
Fortaleza, Ceará, Brazil - Federal University of Pelotas
Pelotas, Rio Grande do Sul, Brazil - Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
|
36 |
NCT03484741 |
Recruiting New |
Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients |
|
|
Interventional |
Phase 1 Phase 2 |
- Van Hanh General Hospital
- University of Science Ho Chi Minh City
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Fasting blood glucose
- Hemoglobin A1c (HbA1c) level
- Adverse events
- (and 3 more...)
|
15 |
All |
18 Years to 45 Years (Adult) |
NCT03484741 |
DIME 1001 |
|
April 1, 2017 |
November 2018 |
November 2018 |
April 2, 2018 |
April 4, 2018 |
|
- Van Hanh Geral Hospital
Ho Chi Minh City, Ho Chi Minh, Vietnam
|
37 |
NCT03061266 |
Recruiting |
The Application of the E-health Education on Shared Care Program for Patients With Type 2 Diabetes |
|
- Behavioral: E-health Education
- Other: Routine care
|
Interventional |
Not Applicable |
- Li-Li Chen
- China Medical University Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Health Services Research
|
- Glycated hemoglobin (HbA1c)
- Perceived diabetes self-management abilty using questionnaire
- quality of life using questionnaire
|
110 |
All |
20 Years and older (Adult, Senior) |
NCT03061266 |
CMUH105-REC2-013 |
|
March 9, 2016 |
March 8, 2017 |
March 8, 2017 |
February 23, 2017 |
February 23, 2017 |
|
- Puli Christian Hospital
Nantou, Taiwan
|
38 |
NCT03428945 |
Not yet recruiting |
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus |
|
- Drug: Hydroxychloroquine
- Drug: Placebo
|
Interventional |
Phase 2 |
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Juvenile Diabetes Research Foundation
|
NIH / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Prevention
|
- Progression to Abnormal Glucose Tolerance or Diabetes
|
201 |
All |
3 Years and older (Child, Adult, Senior) |
NCT03428945 |
Hydroxychloroquine UC4DK117009 UC4DK106993 |
TN-22 |
May 2018 |
May 2024 |
May 2024 |
February 12, 2018 |
February 12, 2018 |
|
|
39 |
NCT02728414 |
Recruiting |
Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Type 2 Diabetes |
- Diabetes Mellitus, Type 2
|
- Dietary Supplement: probiotics
- Dietary Supplement: placebo
|
Interventional |
Not Applicable |
- Shanghai 10th People's Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
|
- change from baseline in fasting blood-glucose at 1 month
- change from baseline in fasting blood-glucose at 3 months
- change from baseline in glycosylated hemoglobin change at 1 month
- (and 33 more...)
|
100 |
All |
20 Years to 80 Years (Adult, Senior) |
NCT02728414 |
PTD01 |
|
October 2015 |
December 2017 |
December 2017 |
April 5, 2016 |
March 10, 2017 |
|
- Shanghai 10th People's Hospital
Shanghai, Shanghai, China
|
40 |
NCT03465878 |
Recruiting |
A Study of LY900014 in Participants With Type 1 Diabetes Mellitus |
|
- Biological: LY900014
- Biological: Insulin Lispro
|
Interventional |
Phase 1 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Basic Science
|
- Pharmacokinetics (PK): Insulin Lispro Area Under the Plasma Concentration Curve (AUC) following Each Treatment Arm for Each Study Part
- Glucodynamics (GD): Area Under the Baseline Subtracted Glucose Concentration versus Time Curve Following each Treatment Arm for Each Study Part
|
45 |
All |
6 Years to 64 Years (Child, Adult) |
NCT03465878 |
16695 I8B-MC-ITSA 2017-003220-78 |
|
March 26, 2018 |
March 18, 2019 |
March 18, 2019 |
March 14, 2018 |
April 9, 2018 |
|
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Toronto, Ontarios, Canada - For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Hannover, Germany
|
41 |
NCT03478254 |
Recruiting New |
Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-1). |
|
- Biological: Influenza vaccination
- Biological: Pneumococcal vaccination
- Biological: Hepatitis B Virus (HBV) vaccination
|
Observational |
|
- Jesús Moreno Fernández
- Castilla-La Mancha Health Service
- University of Castilla-La Mancha
|
Other |
- Observational Model: Cohort
- Time Perspective: Cross-Sectional
|
- Adherence to regional guidelines for the immunization of adults with type 1 diabetes mellitus (T1DM
- Predictors of vaccination
- Relationship between adherence vaccination and related sick leaves
|
300 |
All |
18 Years and older (Adult, Senior) |
NCT03478254 |
C-127 |
AVADI-1 |
December 1, 2017 |
December 1, 2018 |
December 1, 2018 |
March 27, 2018 |
March 29, 2018 |
|
- Obispo Rafael Torija, St.
Ciudad Real, Spain
|
42 |
NCT03407118 |
Recruiting |
A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus |
- Diabetes Mellitus, Type 1
|
- Drug: LY900014
- Drug: Insulin Lispro
|
Interventional |
Phase 1 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Basic Science
|
- Pharmacokinetics (PK): Pharmacokinetics: Area Under the Plasma Concentration Curve (AUC) of Insulin Lispro for Each Treatment Arm
- Total Amount of Glucose Infused (Gtot) Over Duration of Clamp for Each Treatment Arm
|
40 |
All |
18 Years and older (Adult, Senior) |
NCT03407118 |
16645 I8B-MC-ITRZ |
|
February 17, 2018 |
June 2018 |
June 2018 |
January 23, 2018 |
March 7, 2018 |
|
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Fukuoka, Japan
|
43 |
NCT02953249 |
Recruiting |
Wound Healing After Tooth Extraction in Individuals With Type 1 Diabetes Mellitus |
- Diabetes Mellitus, Type 1
|
|
Observational |
|
|
Other |
- Observational Model: Case Control
- Time Perspective: Prospective
|
- Wound healing change after tooth extraction through epithelialization
- Number of participants with abnormal laboratory values
- Adverse events that are related to the surgery
- (and 3 more...)
|
60 |
All |
18 Years and older (Adult, Senior) |
NCT02953249 |
51979315.7.0000.0075 |
|
September 2016 |
June 2017 |
May 2019 |
November 2, 2016 |
November 2, 2016 |
|
- Dental School of University of Sao Paulo
Sao Paulo, SP, Brazil
|
44 |
NCT02717078 |
Recruiting |
The LoBAG Diet and Type 2 Diabetes Mellitus |
|
|
Interventional |
Not Applicable |
- University of Minnesota - Clinical and Translational Science Institute
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Hemoglobin A1c
- Weight
- Fasting plasma glucose
- (and 5 more...)
|
24 |
All |
18 Years to 100 Years (Adult, Senior) |
NCT02717078 |
1601M882501 |
|
March 28, 2017 |
September 2018 |
December 2018 |
March 23, 2016 |
March 31, 2017 |
|
- University of Minnesota
Minneapolis, Minnesota, United States
|
45 |
NCT02306005 |
Recruiting |
Insulin Therapy and Lipoproteins' Profile in Type 1 Diabetes. |
|
|
Observational |
|
- Poznan University of Medical Sciences
- Department of Clinical Biochemistry and Laboratory Medicine
- Department of Internal Medicine and Diabetology
|
Other |
- Observational Model: Case-Only
- Time Perspective: Prospective
|
- Changes in lipoproteins' metabolism
- Factors influencing relationship between insulin treatment and lipoproteins
- Changes in apolipoproteins
- (and 4 more...)
|
100 |
All |
18 Years to 35 Years (Adult) |
NCT02306005 |
PoznanUMS |
InLipoDiab1 |
November 2014 |
December 2018 |
|
December 3, 2014 |
December 3, 2014 |
|
- Department of Internal Medicine and Diabetiology Poznan University of Medical Sciences
Poznan, Poland
|
46 |
NCT03209089 |
Recruiting |
Type 2 Diabetes Mellitus Patients' Characteristics and Management by General Practitioners and Endocrinologists |
|
|
Observational |
|
|
Industry |
- Observational Model: Cohort
- Time Perspective: Other
|
- Demographic parameters before dapagliflozin initiation in T2DM patients managed by GPs
- demographic characteristics of T2DM patients managed by GPs
- clinical characteristics of T2DM patients managed by GPs
|
900 |
All |
18 Years to 100 Years (Adult, Senior) |
NCT03209089 |
D1690R00037 |
|
August 7, 2017 |
December 16, 2018 |
December 16, 2018 |
July 6, 2017 |
April 5, 2018 |
|
- Research Site
Belgorod Region, Shebekino, Russia, Russian Federation - Research Site
Belgorod Region, Volokonovsky R-n, P. Volokonovka, Russia, Russian Federation - Research Site
N. Novgorod Region, Russia, Russian Federation - (and 16 more...)
|
47 |
NCT03332836 |
Recruiting |
Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus |
|
|
Interventional |
Phase 1 |
- Hanmi Pharmaceutical Company Limited
|
Industry |
- Allocation: Non-Randomized
- Intervention Model: Sequential Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Number of participants with adverse events
- Cmax of HM12460A
- AUC of HM12460A
|
48 |
All |
18 Years to 70 Years (Adult, Senior) |
NCT03332836 |
HM-INS-102 |
|
October 25, 2017 |
June 30, 2019 |
June 30, 2019 |
November 6, 2017 |
November 6, 2017 |
|
- Hanmi Investigative Site
Chula Vista, California, United States
|
48 |
NCT02282046 |
Recruiting |
Diabetes Effects on Long-Term Implant Survival and Success |
|
|
Observational |
|
- The University of Texas Health Science Center at San Antonio
- National Institute of Dental and Craniofacial Research (NIDCR)
|
Other / NIH |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- implant complications
- resonance frequency analysis
|
200 |
All |
25 Years and older (Adult, Senior) |
NCT02282046 |
DE023518 R01DE023518 |
|
May 2014 |
June 2018 |
June 2018 |
November 4, 2014 |
August 17, 2017 |
|
- University of Texas Health Science Center At San Antonio
San Antonio, Texas, United States
|
49 |
NCT03112538 |
Recruiting |
Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy |
|
- Device: Insulin Pump
- Drug: Multiple daily injections of insulin
|
Interventional |
Phase 4 |
- Clinical Research Centre, Malaysia
- Medtronic
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- between group difference of HbA1c changes from baseline to 6 months
- Within group difference in HbA1c changes from 6 months to 12 months
- Safety endpoints which are 1) Number of events of severe hypoglycemia 2)Any hospitalizations for hypoglycaemia or hyperglycaemic emergencies 3)Number of events of Diabetic Ketoacidosis (DKA)
- (and 6 more...)
|
118 |
All |
20 Years to 75 Years (Adult, Senior) |
NCT03112538 |
NERP14-019 |
|
January 2016 |
December 2018 |
December 2018 |
April 13, 2017 |
April 13, 2017 |
|
- Hospital Putrajaya
Putrajaya, Wilayah Persekutuan, Malaysia
|
50 |
NCT01889784 |
Recruiting |
Acute Effect of Phototherapy With Light Emitting Diode (LED) on Muscle and Pulmonary Oxygen Consumption on Diabetes Mellitus |
|
- Device: Phototherapy through light emitting diode (LED) - 150J
- Device: Placebo phototherapy - 150J
- Device: Phototherapy through light emitting diode (LED) - 300J
- Device: Placebo phototherapy - 300J
|
Interventional |
Not Applicable |
- Aparecida Maria Catai
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Universidade Federal de Sao Carlos
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Change in muscle oxygen uptake after phototherapy and placebo phototherapy with light emitting diode (LED) - 150J
- Change in muscle oxygen uptake after phototherapy and placebo phototherapy with light emitting diode (LED) - 300J
- Change in pulmonary oxygen uptake after phototherapy and placebo phototherapy with light emitting diode (LED) - 150J
- (and 3 more...)
|
60 |
Male |
45 Years to 65 Years (Adult) |
NCT01889784 |
13573013.1.0000.5504 |
|
August 2013 |
December 2016 |
June 2017 |
June 28, 2013 |
June 8, 2016 |
|
- Universidade Federal de São Carlos
São Carlos, São Paulo, Brazil
|